US Patent 11014991 Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody
Patent 11014991 was granted and assigned to Apogenix on May, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 26, 2019
Date of Patent
May 25, 2021
Patent Applicant
Patent Application Number
16584050
Patent Inventor Names
Meinolf Thiemann
0
Jaromir Sykora
0
Tim Schnyder
0
Oliver Hill
0
Christian Gieffers
0
Christian Merz
0
Harald Fricke
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11014991 Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.